RecruitingNCT04526093

Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

MC-RWE : Real World Evidence in Patient-Reported Outcomes for Medical Cannabis: A Prospective Observational Study

Sponsor

University Health Network, Toronto

Enrollment

1,000 participants

Start Date

Jul 15, 2020

Study Type

OBSERVATIONAL

Conditions

Pain Depression Epilepsy Sleep Anxiety

Summary

This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting real-world information on how medical cannabis is being used by patients with pain, epilepsy, sleep problems, or anxiety and depression — to understand its effects and safety in everyday use. **You may be eligible if...** - You are 19 years of age or older - You have a medical authorization for cannabis from a healthcare provider - Your main reason for using medical cannabis is pain, epilepsy, sleep problems, or anxiety/depression - You agree to use only verified cannabis products during the study **You may NOT be eligible if...** - You do not have a medical authorization for cannabis - You are unwilling to stick to verified products - You are under 19 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.